Oxford Provides $50MM Credit Facility to OncoResponse
Oxford Finance closed a $50 million senior secured term loan with OncoResponse, a clinical-stage biotech company advancing immunotherapies derived from the immune systems of elite cancer responders.
February 16, 2022
Chris Russell | Christopher A. Herr | OncoResponse | Oxford Finance
Ian Koplin